From their update after Q3:
• Improved operating performance
o EBITDA in Q3 of $6.4m
o FY21 YTD EBITDA up 79% to $21.2m
So ebitda should be more around 27m at a guess if Q4 was like Q3
Result and guidance could be a little messy with impacts of jobkeeper/ lockdowns etc But things are definitely improving with their issues being sorted out.
Might be another 6 months before they resume a dividend, we'll have to see.
Share price could easily recover to 40 cents plus once a few more investors realise this has turned a corner and the business is improving again.
CEO was interviewed on coffee microcaps quite awhile ago- just search for it on youtube.
Ann: ENTERS JV - IN VITRO DIAGNOSTIC BLOOD BANK REAGENTS IN CHINA, page-14
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $773.8M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 47.0¢ | 46.5¢ | $311.2K | 667.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85331 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 687058 | 8 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PGC (ASX) Chart |